[
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "ISA sex XML mass IAA MAY LIMITED replicate RECOMMENDED MAJOR TA SHALL AS PURPOSE MIAME III MT INFRINGE characteristics exclamation ALL PRIDE:0000659 instrument FDR REQUIRES IMPORTANT MONDO depletion source name_ and _assay name IDF ID CN PRIDE URL RFC URI RAW MHC EW INFORMATION THE RIGHTS HCD USE FOR individual PMID MS:1001251 PP CS EM CF UBERON alkylation reagent STANDARDS PEPTIDESEQ WILL EBI developmental stage proteomics data acquisition method SWATH MAGE EXPRESS disease stage MINOR disease INCLUDING TIP ... TO PS NOT PATO DOID MOD HTML label fractionation method cell type README HUPO MUST BMC OF LC PROTEOMICS BE MC PMCID VK organism part biological replicate COLUMN XL BTO CELL SILAC PARTICULAR THAT PSI SH QY PRM OR NCBI HF sample BUT file your WARRANTIES II WARRANTY MS EFO SRM DDA AC DIA CID DJ pooled sample ROW data file COULD SHOULD cleavage agent details source name TAB NCE organism JA IS VCF CPTAC spiked compound ANY BRENDA LI collision energy biosample accession number HEREIN NOTE age CL REQUIRED FITNESS technical replicate dissociation method INITIATIVE ENVO DISCLAIMS ancestry category HANCESTRO RECOMMEND PTM PO PATCH SDRF fraction identifier reduction reagent MERCHANTABILITY OPTIONAL TMT ZFA SP NT CV CT IMPLIED SN DTT CLO"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "ISA sex mass IAA MAY LIMITED RECOMMENDED MAJOR TA SHALL AS PURPOSE MIAME III MT INFRINGE ALL PRIDE:0000659 instrument FDR REQUIRES MONDO depletion IDF CN PRIDE URL RFC URI RAW MHC EW INFORMATION THE RIGHTS HCD USE FOR individual PMID MS:1001251 PP CS EM CF UBERON alkylation reagent STANDARDS PEPTIDESEQ WILL EBI proteomics data acquisition method SWATH MAGE EXPRESS disease stage MINOR disease INCLUDING ... TO PS NOT PATO DOID MOD HTML label fractionation method cell type README HUPO MUST BMC OF LC PROTEOMICS BE MC PMCID VK organism part biological replicate COLUMN XL BTO CELL SILAC PARTICULAR THAT PSI SH QY PRM OR NCBI HF BUT WARRANTIES II WARRANTY MS EFO SRM DDA AC DIA CID DJ pooled sample ROW data file COULD SHOULD cleavage agent details NCE TAB organism JA IS VCF CPTAC spiked compound ANY BRENDA LI collision energy biosample accession number HEREIN age CL REQUIRED FITNESS technical replicate dissociation method INITIATIVE ENVO DISCLAIMS ancestry category HANCESTRO RECOMMEND PTM PO PATCH SDRF fraction identifier reduction reagent MERCHANTABILITY OPTIONAL TMT ZFA SP NT CV CT IMPLIED SN DTT CLO"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nliver |UBERON:0002107 |Liver tissue\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hours post fertilization).\n\nBiological Sex\n\nColumn: characteristics[sex]\n\nOntology: PATO\n\nUse lowercase for all values. For cell lines, sex reflects the original donor.\n\nValue |PATO ID |Description\n\nmale |PATO:0000384 |Biological male\nfemale |PATO:0000383 |Biological female\n\nUse not available when sex is unknown, ",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "synthetic peptide sex CL:0000066 organism PATO:0000384 MAY UBERON CL:0000624 APP organism part biological replicate enrichment process UBERON:0000178 developmental stage age CL PATO:0000461 CL:0000815 exclamation ancestry category NCBI HANCESTRO MONDO disease PATO:0000383 depletion PTM PO xenograft ID CL:0000084 SDRF PATO DOID UBERON:0002107 PDX MONDO:0004989 cell type MUST individual EFO"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nFor human-specific metadata (disease staging, comorbidities, treatment history), see Human Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nOrganism\n\nColumn: characteristics[organism]\n\nOntology: NCBI Taxonomy (NCBITaxon)\n\nUse the scientific name in lowercase. The validator will map to the correct ontology term.\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens |NCBITaxon:9606 |Human\nmus musculus |NCBITaxon:10090 |Mouse\n\nOrganism Part / Tissue\n\nColumn: characteristics[organism part]\n\nOntology: UBERON for mammals/vertebrates, Plant Ontology (PO) for plants, FlyBase Anatomy (FBbt) for Drosophila.\n\nUse lowercase for all values. For cell line samples, use not applicable or specify the tissue of origin (e.g., cervix for HeLa).\n\nValue |UBERON ID |Description\n\nblood |UBERON:0000178 |Whole blood\nliver |UBERON:0002107 |Liver tissue\n\nAge\n\nColumn: characteristics[age]\n\nFormat: {Number}{Unit} where Unit is: Y (Years), M (Months), W (Weeks), D (Days).\n\nFor age ranges use: {LowerBound}{Unit}-{UpperBound}{Unit} (e.g., 40Y-50Y).\n\nUse not available when age is unknown, not applicable for immortalized cell lines.\n\nAge Description |SDRF Value\n\n40 years old |40Y\n8 weeks old |8W\n\nDevelopmental Stage\n\nColumn: characteristics[developmental stage]\n\nOntology: UBERON, EFO\n\nValue |Description\n\nadult |Sexually mature organism\nembryonic |Pre-birth/pre-hatching\n\nFor model organisms, use specific stages when applicable: embryonic day 14 (mouse E14), 24 hpf (zebrafish 24 hours post fertilization).\n\nBiological Sex\n\nColumn: characteristics[sex]\n\nOntology: PATO\n\nUse lowercase for all values. For cell lines, sex reflects the original donor.\n\nValue |PATO ID |Description\n\nmale |PATO:0000384 |Biological male\nfemale |PATO:0000383 |Biological female\n\nUse not available when sex is unknown, ",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "synthetic peptide sex CL:0000066 organism PATO:0000384 MAY UBERON CL:0000624 APP organism part biological replicate enrichment process UBERON:0000178 developmental stage age CL PATO:0000461 CL:0000815 ancestry category NCBI HANCESTRO MONDO disease PATO:0000383 depletion PTM PO xenograft ID CL:0000084 SDRF PATO DOID UBERON:0002107 PDX MONDO:0004989 cell type MUST individual EFO"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "tumor grade CHEBI:28748 NCIT:C65107 NCIT:C4870 NCIT:C71732 treatment status breast cancer subtype HIPAA TNM NCIT:C18206 Dukes stage organism part treatment NCIT:C65106 MONDO:0005148 NCIT:C65108 weight IV CHEBI:27899 compound smoking status exclamation NCIT:C15262 disease stage NCIT:C28076 HANCESTRO:0005 dose ancestry category HANCESTRO IMPORTANT MONDO MONDO:0005044 menopausal status ID NCIT:C15632 sampling time point SDRF NCIT:C27971 pre-existing condition GDPR NCIT:C53554 HANCESTRO:0009 Ann Arbor stage NCI NCIT NCIT:C28078 ER body mass index PR TNM staging treatment response individual NCIT:C27966 AJCC"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to clinical studies and healthy human samples.\n\nFor general sample metadata (organism, age, sex, basic disease), see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nDisease Stage\n\nColumn: characteristics[disease stage]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nstage I |NCIT:C27966 |Early localized disease\nstage IV |NCIT:C27971 |Distant metastasis\n\nUse not available when stage is unknown, not applicable for non-cancer samples.\n\nTNM Staging\n\nColumn: characteristics[TNM staging]\n\nOntology: NCI Thesaurus (NCIT)\n\nFormat: T{0-4}N{0-3}M{0-1} where T = tumor size/extent, N = lymph node involvement, M = distant metastasis. Prefix p indicates pathological staging.\n\nValue |Description\n\nT1N0M0 |Small tumor, no nodes, no metastasis\npT2pN1M0 |Pathological staging after surgery\n\nTumor Grade\n\nColumn: characteristics[tumor grade]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\ngrade 1 |NCIT:C28076 |Well differentiated\ngrade 3 |NCIT:C28078 |Poorly differentiated\n\nCancer-Specific Classifications\n\nBreast cancer subtype (characteristics[breast cancer subtype]):\n\nValue |NCIT ID |Description\n\nluminal A |NCIT:C53554 |ER+/PR+, HER2-, low Ki67\ntriple-negative |NCIT:C71732 |ER-/PR-/HER2-\n\nOther classifications: characteristics[Dukes stage] for colorectal cancer, characteristics[Ann Arbor stage] for lymphoma.\n\nPre-existing Condition\n\nColumn: characteristics[pre-existing condition]\n\nOntology: MONDO Disease Ontology\n\nFor multiple conditions, use multiple columns (preferred) or semicolon-separated values.\n\nCondition |SDRF Value |MONDO ID\n\nHigh blood pressure |hypertension |MONDO:0005044\nDiabetes |type 2 diabetes mellitus |MONDO:0005148\n\nTreatment\n\nColumn: characteristics[treatment]\n\nOntology: NCI Thesaurus (NCIT)\n\nValue |NCIT ID |Description\n\nchemotherapy |NCIT:C15632 |Chemical drug treatm",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "tumor grade CHEBI:28748 NCIT:C65107 NCIT:C4870 NCIT:C71732 treatment status breast cancer subtype HIPAA TNM NCIT:C18206 Dukes stage organism part treatment NCIT:C65106 MONDO:0005148 NCIT:C65108 weight IV CHEBI:27899 compound smoking status NCIT:C15262 disease stage NCIT:C28076 HANCESTRO:0005 dose ancestry category HANCESTRO MONDO MONDO:0005044 menopausal status ID NCIT:C15632 sampling time point SDRF NCIT:C27971 pre-existing condition GDPR NCIT:C53554 HANCESTRO:0009 Ann Arbor stage NCI NCIT NCIT:C28078 ER body mass index PR TNM staging treatment response individual NCIT:C27966 AJCC"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format, describing the relationship between samples and MS run files, instrument configurations, and analysis parameters.\n\nData file properties use the comment prefix to differentiate from sample properties (characteristics).\n\nFor sample metadata guidelines, see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nAssay Name\n\nColumn: assay name\n\nUnique identifier for an MS run (data file). Each distinct MS run MUST have exactly one globally unique assay name.\n\nUniqueness rules:\n\n- source name + assay name + comment[label] MUST be unique (error if not)\n- source name + assay name SHOULD be unique (warning if not)\n\nFormat |Example\n\nsamplerun |sample1run1\nsamplefractionreplicate |sample1F1R1\n\nFor multiplexed experiments (TMT, iTRAQ, SILAC), multiple rows may reference the same assay name with different labels.\n\nTechnology Type\n\nColumn: technology type\n\nOntology: PRIDE Ontology (PRIDE:0000663)\n\nREQUIRED for all MS-based SDRF files. Should be placed immediately after assay name.\n\nValue |Use Case\n\nproteomic profiling by mass spectrometry |DDA, DIA, PRM, SRM experiments\nprotein profiling by proximity extension assay |Olink panels\n\nData Acquisition Method\n\nColumn: comment[proteomics data acquisition method]\n\nOntology: PRIDE Ontology\n\nREQUIRED for all MS-based SDRF files.\n\nValue |Description\n\ndata-dependent acquisition |DDA - precursors selected based on intensity\ndata-independent acquisition |DIA - systematic fragmentation of all precursors\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "MS:1001251 PP fragment mass tolerance MS1 scan range RECOMMENDED precursor mass tolerance scan window upper limit TA PRIDE:0000663 SILAC proteomics data acquisition method PSI REQUIRED technical replicate MT PRM exclamation instrument HF modification parameters file uri MGF fraction ID SDRF fraction identifier MOD MS2 analyzer type PRIDE URL MS UNIMOD:4 SRM URI label scan window lower limit TMT DDA DIA AC MS:1001309 RAW NT data file UNIMOD:35 SHOULD MUST UNIMOD cleavage agent details proteomexchange accession number"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nIntroduction\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format, describing the relationship between samples and MS run files, instrument configurations, and analysis parameters.\n\nData file properties use the comment prefix to differentiate from sample properties (characteristics).\n\nFor sample metadata guidelines, see Sample Metadata Guidelines.\n\nVersion 1.0.0 - 2025-01\n\nAssay Name\n\nColumn: assay name\n\nUnique identifier for an MS run (data file). Each distinct MS run MUST have exactly one globally unique assay name.\n\nUniqueness rules:\n\n- source name + assay name + comment[label] MUST be unique (error if not)\n- source name + assay name SHOULD be unique (warning if not)\n\nFormat |Example\n\nsamplerun |sample1run1\nsamplefractionreplicate |sample1F1R1\n\nFor multiplexed experiments (TMT, iTRAQ, SILAC), multiple rows may reference the same assay name with different labels.\n\nTechnology Type\n\nColumn: technology type\n\nOntology: PRIDE Ontology (PRIDE:0000663)\n\nREQUIRED for all MS-based SDRF files. Should be placed immediately after assay name.\n\nValue |Use Case\n\nproteomic profiling by mass spectrometry |DDA, DIA, PRM, SRM experiments\nprotein profiling by proximity extension assay |Olink panels\n\nData Acquisition Method\n\nColumn: comment[proteomics data acquisition method]\n\nOntology: PRIDE Ontology\n\nREQUIRED for all MS-based SDRF files.\n\nValue |Description\n\ndata-dependent acquisition |DDA - precursors selected based on intensity\ndata-independent acquisition |DIA - systematic fragmentation of all precursors\n\nLabel\n\nColumn: comment[label]\n\nOntology: PRIDE Ontology - Label\n\nDescribes the isotopic label applied to each sample.\n\nLabel-free: Use label free sample.\n\nTMT labels: TMT126, TMT127N, TMT127C, TMT128N, TMT128C, TMT129N, TMT129C, TMT130N, TMT130C, TMT131N, TMT131C, TMT132N, TMT132C, TMT133N, TMT133C, TMT134N, TMT134C, TMT135N\n\niTRAQ labels: iTRAQ113, iTRAQ114, iTRAQ115, iTRAQ116, iTRAQ117, iTRAQ118, iTRAQ119",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "MS:1001251 PP fragment mass tolerance MS1 scan range RECOMMENDED precursor mass tolerance scan window upper limit TA PRIDE:0000663 SILAC proteomics data acquisition method PSI REQUIRED technical replicate MT PRM instrument HF modification parameters file uri MGF ID SDRF fraction identifier MOD MS2 analyzer type PRIDE URL MS UNIMOD:4 SRM URI label scan window lower limit TMT DDA DIA AC MS:1001309 RAW NT data file UNIMOD:35 SHOULD MUST UNIMOD cleavage agent details proteomexchange accession number"
  }
]